- Home
- CION vs ARCT Comparison
CION vs ARCT Comparison
Compare CION & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CION
- ARCT
- Stock Information
- Founded
- CION 2011
- ARCT 2013
- Country
- CION United States
- ARCT United States
- Employees
- CION N/A
- ARCT N/A
- Industry
- CION Finance/Investors Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- CION Finance
- ARCT Health Care
- Exchange
- CION Nasdaq
- ARCT Nasdaq
- Market Cap
- CION 491.6M
- ARCT 444.5M
- IPO Year
- CION N/A
- ARCT N/A
- Fundamental
- Price
- CION $9.45
- ARCT $10.53
- Analyst Decision
- CION Sell
- ARCT Strong Buy
- Analyst Count
- CION 2
- ARCT 7
- Target Price
- CION $11.50
- ARCT $57.80
- AVG Volume (30 Days)
- CION 525.6K
- ARCT 462.9K
- Earning Date
- CION 05-08-2025
- ARCT 05-07-2025
- Dividend Yield
- CION 16.35%
- ARCT N/A
- EPS Growth
- CION N/A
- ARCT N/A
- EPS
- CION 0.63
- ARCT N/A
- Revenue
- CION $252,432,000.00
- ARCT $152,310,000.00
- Revenue This Year
- CION N/A
- ARCT N/A
- Revenue Next Year
- CION N/A
- ARCT $39.21
- P/E Ratio
- CION $14.93
- ARCT N/A
- Revenue Growth
- CION 0.57
- ARCT N/A
- 52 Week Low
- CION $8.51
- ARCT $8.04
- 52 Week High
- CION $12.71
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- CION 40.16
- ARCT 43.14
- Support Level
- CION $8.54
- ARCT $10.07
- Resistance Level
- CION $9.39
- ARCT $11.00
- Average True Range (ATR)
- CION 0.42
- ARCT 0.88
- MACD
- CION 0.02
- ARCT 0.26
- Stochastic Oscillator
- CION 45.85
- ARCT 77.81
About CION CION Investment Corporation
CION Invt Corp is an externally managed, non-diversified, closed-end management investment company that has elected to be regulated as a business development company. The Company's portfolio is comprised of investments in senior secured debt, including first lien loans, second lien loans, and unitranche loans, and, to a lesser extent, collateralized securities, structured products and other similar securities, unsecured debt, and equity, of private and thinly-traded U.S. middle-market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation for investors.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.